Saskatchewan’s chief medical health officer Dr. Saqib Shahab reassured the public on Tuesday on the safety of the AstraZeneca COVID-19 vaccine after Canada announced its first report of a blood clot in a recipient, saying the system to investigate and manage these rare side effects is well-developed, and that the risks of COVID-19 still outweigh the risks of the vaccines’ side effects.
AstraZeneca vaccine
Saskatchewan’s top doctor reassures safety of AstraZeneca COVID-19 vaccine after 1st blood clot reported in Canada
More Videos
-
COVID-19: Mixed messaging around AstraZeneca vaccine highlights public distrust, uncertainty
-
Global News at 6 Regina — May 12, 2021
-
Saskatchewan’s top doctor renews call for vigilance amid recent cluster outbreaks
-
COVID-19: Saskatchewan to lower AstraZeneca vaccine eligibility age to 40 years and older
-
Including AstraZeneca into Saskatchewan’s vaccination plan
You are viewing an Accelerated Mobile Webpage.
View Original Article